
Hi {{ first_name| strip | default: there}},
I cut a longevity supplement from my protocol this week.
Not due to cost, or even inconvenience (although the pill fatigue is real). I stopped it due to new data.
Astaxanthin was a winner in the longevity research program in 2023.
This year, the NIH's ITP longevity research program retested it — different dose, same mice — and the lifespan signal disappeared.
This is what updating protocols based on data actually looks like. It’s an important aspect of longevity medicine, which should be based on evidence which is ever-changing.
The ITP just published its 2026 results. Eight compounds tested. All failed. But the story isn't that nothing in longevity works — it's about what the failures tell us, and what's actually earned its place in the protocol.
One more thing: I'm going to show you the exact four-question framework I use to decide what stays in my protocol when data shifts. If you've ever wondered how to actually update your supplement stack rationally — not reactively — read till the end.

